Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 116

    2.

    Cellular immune responses to human papillomavirus (HPV)-16 L1 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles.

    Pinto LA, Edwards J, Castle PE, Harro CD, Lowy DR, Schiller JT, Wallace D, Kopp W, Adelsberger JW, Baseler MW, Berzofsky JA, Hildesheim A.

    J Infect Dis. 2003 Jul 15;188(2):327-38. Epub 2003 Jul 9.

    PMID:
    12854090
    [PubMed - indexed for MEDLINE]
    Free Article
    3.

    Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines.

    Jagu S, Karanam B, Gambhira R, Chivukula SV, Chaganti RJ, Lowy DR, Schiller JT, Roden RB.

    J Natl Cancer Inst. 2009 Jun 3;101(11):782-92. Epub 2009 May 26.

    PMID:
    19470949
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    4.

    Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

    Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER; Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP).

    MMWR Recomm Rep. 2007 Mar 23;56(RR-2):1-24.

    PMID:
    17380109
    [PubMed - indexed for MEDLINE]
    Free Article
    5.

    Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only.

    Giannini SL, Hanon E, Moris P, Van Mechelen M, Morel S, Dessy F, Fourneau MA, Colau B, Suzich J, Losonksy G, Martin MT, Dubin G, Wettendorff MA.

    Vaccine. 2006 Aug 14;24(33-34):5937-49. Epub 2006 Jun 19.

    PMID:
    16828940
    [PubMed - indexed for MEDLINE]
    6.

    Mucosal immunisation with papillomavirus virus-like particles elicits systemic and mucosal immunity in mice.

    Liu XS, Abdul-Jabbar I, Qi YM, Frazer IH, Zhou J.

    Virology. 1998 Dec 5;252(1):39-45.

    PMID:
    9875315
    [PubMed - indexed for MEDLINE]
    7.

    Human papillomavirus type 11 (HPV-11) neutralizing antibodies in the serum and genital mucosal secretions of African green monkeys immunized with HPV-11 virus-like particles expressed in yeast.

    Lowe RS, Brown DR, Bryan JT, Cook JC, George HA, Hofmann KJ, Hurni WM, Joyce JG, Lehman ED, Markus HZ, Neeper MP, Schultz LD, Shaw AR, Jansen KU.

    J Infect Dis. 1997 Nov;176(5):1141-5.

    PMID:
    9359711
    [PubMed - indexed for MEDLINE]
    Free Article
    8.

    A nontoxic derivative of lipopolysaccharide increases immune responses to Gardasil HPV vaccine in mice.

    Han JE, Kim HK, Park SA, Lee SJ, Kim HJ, Son GH, Kim YT, Cho YJ, Kim HJ, Lee NG.

    Int Immunopharmacol. 2010 Feb;10(2):169-76. Epub 2009 Oct 28.

    PMID:
    19874917
    [PubMed - indexed for MEDLINE]
    9.

    Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.

    Yang R, Wheeler CM, Chen X, Uematsu S, Takeda K, Akira S, Pastrana DV, Viscidi RP, Roden RB.

    J Virol. 2005 Jun;79(11):6741-50.

    PMID:
    15890912
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    10.

    Correlating immunity with protection for HPV infection.

    Frazer I.

    Int J Infect Dis. 2007 Nov;11 Suppl 2:S10-6. Review.

    PMID:
    18162240
    [PubMed - indexed for MEDLINE]
    11.

    Immunization of early adolescent females with human papillomavirus type 16 and 18 L1 virus-like particle vaccine containing AS04 adjuvant.

    Pedersen C, Petaja T, Strauss G, Rumke HC, Poder A, Richardus JH, Spiessens B, Descamps D, Hardt K, Lehtinen M, Dubin G; HPV Vaccine Adolescent Study Investigators Network.

    J Adolesc Health. 2007 Jun;40(6):564-71.

    PMID:
    17531764
    [PubMed - indexed for MEDLINE]
    12.

    Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial.

    Mao C, Koutsky LA, Ault KA, Wheeler CM, Brown DR, Wiley DJ, Alvarez FB, Bautista OM, Jansen KU, Barr E.

    Obstet Gynecol. 2006 Jan;107(1):18-27. Erratum in: Obstet Gynecol. 2006 Jun;107(6):1425.

    PMID:
    16394035
    [PubMed - indexed for MEDLINE]
    13.

    Developing an HPV vaccine to prevent cervical cancer and genital warts.

    Bryan JT.

    Vaccine. 2007 Apr 20;25(16):3001-6. Epub 2007 Jan 18. Review.

    PMID:
    17289220
    [PubMed - indexed for MEDLINE]
    14.

    A pan-HPV vaccine based on bacteriophage PP7 VLPs displaying broadly cross-neutralizing epitopes from the HPV minor capsid protein, L2.

    Tumban E, Peabody J, Peabody DS, Chackerian B.

    PLoS One. 2011;6(8):e23310. Epub 2011 Aug 17.

    PMID:
    21858066
    [PubMed - in process]
    Free PMC Article
    15.

    Binding of human papilloma virus L1 virus-like particles to dendritic cells is mediated through heparan sulfates and induces immune activation.

    de Witte L, Zoughlami Y, Aengeneyndt B, David G, van Kooyk Y, Gissmann L, Geijtenbeek TB.

    Immunobiology. 2007;212(9-10):679-91. Epub 2007 Nov 14.

    PMID:
    18086370
    [PubMed - indexed for MEDLINE]
    16.

    The humoral response to Gardasil over four years as defined by total IgG and competitive Luminex immunoassay.

    Brown DR, Garland SM, Ferris DG, Joura E, Steben M, James M, Radley D, Vuocolo S, Garner EI, Haupt RM, Bryan JT.

    Hum Vaccin. 2011 Feb;7(2):230-8. Epub 2011 Feb 1.

    PMID:
    21307649
    [PubMed - indexed for MEDLINE]
    17.

    Human papillomavirus types 16 and 18 vaccine (recombinant, AS04 adjuvanted, adsorbed) [Cervarix].

    Keam SJ, Harper DM.

    Drugs. 2008;68(3):359-72. Review.

    PMID:
    18257611
    [PubMed - indexed for MEDLINE]
    18.

    Antibody, cytokine and cytotoxic T lymphocyte responses in chimpanzees immunized with human papillomavirus virus-like particles.

    Palker TJ, Monteiro JM, Martin MM, Kakareka C, Smith JF, Cook JC, Joyce JG, Jansen KU.

    Vaccine. 2001 Jun 14;19(27):3733-43.

    PMID:
    11395208
    [PubMed - indexed for MEDLINE]
    19.

    Effect of alternative aluminum adjuvants on the absorption and immunogenicity of HPV16 L1 VLPs in mice.

    Caulfield MJ, Shi L, Wang S, Wang B, Tobery TW, Mach H, Ahl PL, Cannon JL, Cook JC, Heinrichs JH, Sitrin RD.

    Hum Vaccin. 2007 Jul-Aug;3(4):139-45. Epub 2007 Apr 5.

    PMID:
    17581283
    [PubMed - indexed for MEDLINE]
    Free Article
    20.

    Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine.

    Olsson SE, Villa LL, Costa RL, Petta CA, Andrade RP, Malm C, Iversen OE, Høye J, Steinwall M, Riis-Johannessen G, Andersson-Ellstrom A, Elfgren K, von Krogh G, Lehtinen M, Paavonen J, Tamms GM, Giacoletti K, Lupinacci L, Esser MT, Vuocolo SC, Saah AJ, Barr E.

    Vaccine. 2007 Jun 21;25(26):4931-9. Epub 2007 Apr 20.

    PMID:
    17499406
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk